MCCLUSKI STEPHEN C 4
4 · ImmunoGen, Inc. · Filed Jun 16, 2023
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
MCCLUSKI STEPHEN C
Director
Transactions
- Award
Restricted Stock Unit
2023-06-14+13,090→ 13,090 totalExercise: $0.00→ Common Stock (13,090 underlying) - Award
Stock Option (right to buy)
2023-06-14+19,597→ 19,597 totalExercise: $17.72Exp: 2033-06-14→ Common Stock (19,597 underlying)
Footnotes (4)
- [F1]The restricted stock units ("RSUs") were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors, as amended, and the 2018 Employee, Director and Consultant Equity Incentive Plan, as amended. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F2]The restricted stock units vest on the one-year anniversary of the date of grant, contingent upon the individual remaining a director as of the vesting date.
- [F3]The stock options were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors, as amended, and the 2018 Employee, Director and Consultant Equity Incentive Plan, as amended.
- [F4]The stock options vest ratably on each of 9/1/23, 12/1/23, 3/1/24, and 6/1/24, contingent upon the individual remaining a director as of each vesting date.